Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
VIMP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CDV3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IGFBP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NIPA2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CADM1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PARD3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CCR10 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SECISBP2L - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SNRPA1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HIST1H3F - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
SEC11A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ITGA8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NAV1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HIST1H2AE - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EGLN1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PCP4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LPCAT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IFT57 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SBF1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on